title: [Multidisciplinary therapy for 984 cancer patients--hyperthermic immunotherapy].
abstract: We treated 984 advanced or recurrent cancer patients with hyperthermia or immunotherapy (2005/7-2009/12). We have 137 clinical benefit cases (CR, PR and long SD) including 22 complete response (CR) cases. Effective rates of immunotherapy increased from 9.8% to 17.8% using hyperthermia. In the cases of ovarian cancer, head and neck cancer, lung cancer, prostatic cancer, gastric cancer, thyroid cancer and breast cancer, all confirmed high effective rates with hyperthermic immunotherapy.
authors.affiliation: Osaka Cancer Immuno-Chemotherapy Center.
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Takeda
authors.forename: Kenki
authors.initials: K
authors.lastname: Miyazawa
authors.forename: Takashi
authors.initials: T
authors.lastname: Takeda
authors.forename: Hiroko
authors.initials: H
authors.lastname: Takeda
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Takeda
mesh_terms: D001943:Breast Neoplasms / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000628:therapy; D012074:Remission Induction; D016896:Treatment Outcome